A small sample study showed that preoperative treatment with cabergoline improved biochemical control in acromegaly patients, with tumor volume changes mainly observed in GH/prolactin co-secreting tumors, and less frequently in tumors that solely secrete GH (46, 47). Here, GH1 is linked to acromegaly.